Orphenadrine Citrate
Product Images NDC 0115-2011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 0115-2011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 (Orphenadrine Citrate Extended Release Tablets 1)

Orphenadrine Citrate is a medication available in extended-release tablets form. The usual dosage information can be found on the accompanying outer packaging. It is important to keep the medication out of reach of children and dispense it in a tightly closed container, as per USP guidelines. The package contains 100 tablets and is distributed by Amneal Pharmaceuticals LLC in Bridgevater, J 08807. The Lot and Exp. Date are mentioned in a non-varnish area of the package.*

FDA Label Image

1 (Orphenadrine Citrate Extended Release Tablets 2)

This text is the label of a medication package of Orphenadrine Citrate Extended-Release Tablets. It provides instructions on storage, dispensing, and dosage. It also warns to keep it out of reach of children. It was distributed by Amneal Pharmaceuticals LLC, located in Bridgewater, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.